Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo

Hitoshi Yamazaki; Yoshiyuki Abe; Yuko Katoh; Nobuko Sawa; Yasuyuki Ohnishi; Yuji Tanaka; Hironobu Sasano; Yoshiro Oshika; Testuji Tokunaga; Hiroshi Kijima; Norikazu Tamaoki; Masato Nakamura; Yoshito Ueyama

doi:10.1111/j.1699-0463.1998.tb00258.x

Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo

Hitoshi Yamazaki, Yoshiyuki Abe, Yuko Katoh, Nobuko Sawa, Yasuyuki Ohnishi, Yuji Tanaka, Hironobu Sasano, Yoshiro Oshika, Testuji Tokunaga, Hiroshi Kijima, Norikazu Tamaoki, Masato Nakamura, Yoshito Ueyama

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

We established a xenograft line of human adrenocortical carcinoma (ADR- 1), and analyzed the hyperaldosteronism induced by the xenograft in vivo. Adrenocortical carcinoma specimens from a 25-year-old woman were subcutaneously inoculated into nude mice (BALB/c-nu/nu) followed by serial passages in vivo. ADR-1 retained the histopathological features (trabecular and sinusoid nests) seen in the primary carcinoma. The patient showed hyperaldosteronism (serum aldosterone >4000 pg/ml) and hypokalemia (serum K 2.1 mEq/l), but did not show hypertension. The nude rat (F344-rnu/rnu) bearing ADR-1 showed hyperaldosteronism (serum aldosterone 3320±1420 pg/ml; control 191±130 pg/ml) and hypokalemia (serum K 3.4+0.4 mEq/1; control 5.2±1.0 mEq/1) in vivo, and hypertension was not obvious. ADR-1 was shown immunohistochemically to retain production of human-specific corticosteroid synthetase. The xenograft ADR-1 will be useful to elucidate the regulatory mechanism of normotensive hyperaldosteronism.

Original language	English
Pages (from-to)	1056-1060
Number of pages	5
Journal	APMIS
Volume	106
Issue number	11
DOIs	https://doi.org/10.1111/j.1699-0463.1998.tb00258.x
Publication status	Published - 1998
Externally published	Yes

Keywords

Adrenocortical carcinoma
Aldosterone
Xenograft

ASJC Scopus subject areas

Pathology and Forensic Medicine
Immunology and Allergy
Microbiology (medical)

Access to Document

10.1111/j.1699-0463.1998.tb00258.x

Cite this

@article{9b20b6a594714500ade31f0595548dba,

title = "Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo",

abstract = "We established a xenograft line of human adrenocortical carcinoma (ADR- 1), and analyzed the hyperaldosteronism induced by the xenograft in vivo. Adrenocortical carcinoma specimens from a 25-year-old woman were subcutaneously inoculated into nude mice (BALB/c-nu/nu) followed by serial passages in vivo. ADR-1 retained the histopathological features (trabecular and sinusoid nests) seen in the primary carcinoma. The patient showed hyperaldosteronism (serum aldosterone >4000 pg/ml) and hypokalemia (serum K 2.1 mEq/l), but did not show hypertension. The nude rat (F344-rnu/rnu) bearing ADR-1 showed hyperaldosteronism (serum aldosterone 3320±1420 pg/ml; control 191±130 pg/ml) and hypokalemia (serum K 3.4+0.4 mEq/1; control 5.2±1.0 mEq/1) in vivo, and hypertension was not obvious. ADR-1 was shown immunohistochemically to retain production of human-specific corticosteroid synthetase. The xenograft ADR-1 will be useful to elucidate the regulatory mechanism of normotensive hyperaldosteronism.",

keywords = "Adrenocortical carcinoma, Aldosterone, Xenograft",

author = "Hitoshi Yamazaki and Yoshiyuki Abe and Yuko Katoh and Nobuko Sawa and Yasuyuki Ohnishi and Yuji Tanaka and Hironobu Sasano and Yoshiro Oshika and Testuji Tokunaga and Hiroshi Kijima and Norikazu Tamaoki and Masato Nakamura and Yoshito Ueyama",

year = "1998",

doi = "10.1111/j.1699-0463.1998.tb00258.x",

language = "English",

volume = "106",

pages = "1056--1060",

journal = "APMIS",

issn = "0903-4641",

number = "11",

}

TY - JOUR

T1 - Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo

AU - Yamazaki, Hitoshi

AU - Abe, Yoshiyuki

AU - Katoh, Yuko

AU - Sawa, Nobuko

AU - Ohnishi, Yasuyuki

AU - Tanaka, Yuji

AU - Sasano, Hironobu

AU - Oshika, Yoshiro

AU - Tokunaga, Testuji

AU - Kijima, Hiroshi

AU - Tamaoki, Norikazu

AU - Nakamura, Masato

AU - Ueyama, Yoshito

PY - 1998

Y1 - 1998

N2 - We established a xenograft line of human adrenocortical carcinoma (ADR- 1), and analyzed the hyperaldosteronism induced by the xenograft in vivo. Adrenocortical carcinoma specimens from a 25-year-old woman were subcutaneously inoculated into nude mice (BALB/c-nu/nu) followed by serial passages in vivo. ADR-1 retained the histopathological features (trabecular and sinusoid nests) seen in the primary carcinoma. The patient showed hyperaldosteronism (serum aldosterone >4000 pg/ml) and hypokalemia (serum K 2.1 mEq/l), but did not show hypertension. The nude rat (F344-rnu/rnu) bearing ADR-1 showed hyperaldosteronism (serum aldosterone 3320±1420 pg/ml; control 191±130 pg/ml) and hypokalemia (serum K 3.4+0.4 mEq/1; control 5.2±1.0 mEq/1) in vivo, and hypertension was not obvious. ADR-1 was shown immunohistochemically to retain production of human-specific corticosteroid synthetase. The xenograft ADR-1 will be useful to elucidate the regulatory mechanism of normotensive hyperaldosteronism.

AB - We established a xenograft line of human adrenocortical carcinoma (ADR- 1), and analyzed the hyperaldosteronism induced by the xenograft in vivo. Adrenocortical carcinoma specimens from a 25-year-old woman were subcutaneously inoculated into nude mice (BALB/c-nu/nu) followed by serial passages in vivo. ADR-1 retained the histopathological features (trabecular and sinusoid nests) seen in the primary carcinoma. The patient showed hyperaldosteronism (serum aldosterone >4000 pg/ml) and hypokalemia (serum K 2.1 mEq/l), but did not show hypertension. The nude rat (F344-rnu/rnu) bearing ADR-1 showed hyperaldosteronism (serum aldosterone 3320±1420 pg/ml; control 191±130 pg/ml) and hypokalemia (serum K 3.4+0.4 mEq/1; control 5.2±1.0 mEq/1) in vivo, and hypertension was not obvious. ADR-1 was shown immunohistochemically to retain production of human-specific corticosteroid synthetase. The xenograft ADR-1 will be useful to elucidate the regulatory mechanism of normotensive hyperaldosteronism.

KW - Adrenocortical carcinoma

KW - Aldosterone

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=0032440634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032440634&partnerID=8YFLogxK

U2 - 10.1111/j.1699-0463.1998.tb00258.x

DO - 10.1111/j.1699-0463.1998.tb00258.x

M3 - Article

C2 - 9890267

AN - SCOPUS:0032440634

VL - 106

SP - 1056

EP - 1060

JO - APMIS

JF - APMIS

SN - 0903-4641

IS - 11

ER -

Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this